(1)
Sunitinib Induced Resistance of Endothelial Cells by up-Regulating P-Glycoprotein and PI3K Akt Pathway. Braz. J. Pharm. Sci. 2022, 58. https://doi.org/10.1590/s2175-97902022e191102.